Goldman Sachs’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.9M Sell
219,755
-180,523
-45% -$14.1M ﹤0.01% 2593
2025
Q4
$31.6M Buy
400,278
+21,252
+6% +$1.84M ﹤0.01% 1927
2025
Q3
$34.7M Buy
379,026
+173,406
+84% +$14.1M 0.01% 1737
2025
Q2
$13.4M Sell
205,620
-426,166
-67% -$27.7M ﹤0.01% 2488
2025
Q1
$42.3M Sell
631,786
-67,832
-10% -$4.05M 0.01% 1339
2024
Q4
$38.7M Sell
699,618
-16,451
-2% -$944K 0.01% 1521
2024
Q3
$42.7M Buy
716,069
+626,110
+696% +$38.2M 0.01% 1374
2024
Q2
$5.73M Buy
89,959
+24,169
+37% +$1.57M ﹤0.01% 3027
2024
Q1
$4.55M Buy
65,790
+24,589
+60% +$1.48M ﹤0.01% 3176
2023
Q4
$2.27M Buy
41,201
+2,007
+5% +$111K ﹤0.01% 3820
2023
Q3
$2.28M Sell
39,194
-34,021
-46% -$1.96M ﹤0.01% 3666
2023
Q2
$3.94M Buy
73,215
+6,066
+9% +$269K ﹤0.01% 3312
2023
Q1
$2.67M Sell
67,149
-5,237
-7% -$221K ﹤0.01% 3621
2022
Q4
$2.91M Sell
72,386
-20,240
-22% -$760K ﹤0.01% 3636
2022
Q3
$2.98M Sell
92,626
-43,183
-32% -$1.48M ﹤0.01% 3608
2022
Q2
$4.03M Buy
135,809
+120,178
+769% +$3.47M ﹤0.01% 3361
2022
Q1
$439K Sell
15,631
-22,564
-59% -$841K ﹤0.01% 5405
2021
Q4
$1.76M Sell
38,195
-273,067
-88% -$11.7M ﹤0.01% 4355
2021
Q3
$10.2M Sell
311,262
-50,482
-14% -$1.57M ﹤0.01% 2703
2021
Q2
$12.7M Buy
361,744
+23,376
+7% +$795K ﹤0.01% 2472
2021
Q1
$12.2M Sell
338,368
-4,160
-1% -$130K ﹤0.01% 2381
2020
Q4
$9.95M Buy
342,528
+30,269
+10% +$867K ﹤0.01% 2476
2020
Q3
$8.81M Buy
312,259
+38,400
+14% +$1.14M ﹤0.01% 2434
2020
Q2
$8.86M Sell
273,859
-7,562
-3% -$271K ﹤0.01% 2368
2020
Q1
$11.5M Buy
281,421
+2,691
+1% +$143K ﹤0.01% 1988
2019
Q4
$17.2M Buy
278,730
+53,577
+24% +$3.55M ﹤0.01% 1994
2019
Q3
$16.4M Buy
225,153
+178,875
+387% +$13.4M 0.01% 1941
2019
Q2
$3.8M Sell
46,278
-8,935
-16% -$635K ﹤0.01% 3048
2019
Q1
$3.9M Buy
55,213
+3,375
+7% +$199K ﹤0.01% 3181
2018
Q4
$2.33M Sell
51,838
-53,066
-51% -$2.78M ﹤0.01% 3430
2018
Q3
$5.93M Buy
104,904
+10,750
+11% +$658K ﹤0.01% 2855
2018
Q2
$6.29M Buy
94,154
+11,856
+14% +$740K ﹤0.01% 2800
2018
Q1
$4.79M Buy
82,298
+47,018
+133% +$2.98M ﹤0.01% 2927
2017
Q4
$2.27M Sell
35,280
-8,186
-19% -$509K ﹤0.01% 3678
2017
Q3
$2.28M Buy
43,466
+27,223
+168% +$1.3M ﹤0.01% 3867
2017
Q2
$760K Sell
16,243
-4,336
-21% -$209K ﹤0.01% 4716
2017
Q1
$1.02M Sell
20,579
-3,014
-13% -$169K ﹤0.01% 4361
2016
Q4
$1.43M Buy
23,593
+10,987
+87% +$672K ﹤0.01% 4148
2016
Q3
$836K Buy
12,606
+3,018
+31% +$189K ﹤0.01% 4576
2016
Q2
$535K Sell
9,588
-6,301
-40% -$306K ﹤0.01% 4793
2016
Q1
$535K Buy
15,889
+3,432
+28% +$116K ﹤0.01% 4678
2015
Q4
$562K Buy
12,457
+2,848
+30% +$123K ﹤0.01% 4821
2015
Q3
$380K Sell
9,609
-19,452
-67% -$1.11M ﹤0.01% 5405
2015
Q2
$1.8M Buy
29,061
+10,972
+61% +$653K ﹤0.01% 3936
2015
Q1
$1.13M Buy
+18,089
New +$1.1M ﹤0.01% 4335
2014
Q3
Sell
-30,201
Closed -$1.04M 7100
2014
Q2
$1.04M Buy
30,201
+21,952
+266% +$688K ﹤0.01% 4653
2014
Q1
$259K Buy
+8,249
New +$219K ﹤0.01% 5843
2013
Q3
Sell
-5,485
Closed -$33K 6551
2013
Q2
$33K Buy
+5,485
New +$38.4K ﹤0.01% 6130

Other funds holding ANIP